Latest Posts

COVID-19 Vaccine Update India: Big news about the Kovid-19 vaccine, DCGI allowed Serum Institute of India to resume trial of Oxford’s Kovid-19 vaccine

- Advertisement -

COVID-19 Vaccine Update India: Big news about Kovid-19 vaccine, DCGI allowed Serum Institute of India to resume testing of Kovid-19 vaccine at Oxford

- Advertisement -

(Photo Credits: PTI)

New Delhi, 16 September: Drugs Controller General of India Dr. VG Somani on Tuesday allowed the Serum Institute of India (SII) to resume clinical trials (clinical trials) on candidates for Oxford’s Kovid-19 vaccine. DCGI rescinded its earlier order prohibiting the selection of any candidate for the second and third phase trials.

- Advertisement -

However, DCGI has kept many other conditions including extra attention during the investigation for this. SII has been asked by DGCI to submit information about treatment as per rules in dealing with adverse situations.

Also read: Corona pandemic: 37 Indians including 363 NORI visa holders stranded in Pakistan due to Corona crisis return to India

- Advertisement -

Earlier on September 11, DCGI directed the Serum Institute of India to stop the clinical trial of a possible vaccine for Kovid-19 as the pharmaceutical company Astragenica reported ‘ill-health’ of one person involved in the study. Testing was stopped in countries.

- Advertisement -

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Latest Posts

Don't Miss